Skip to main content

Stablecoin Development Corp

For the period ended Mar 31, 2026. Filed Apr 1, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Mar 31, 2026 · Filed Apr 1, 2026

Use the contents to explore the available documents and sections.

SDEV$0.98+9.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cautionary Language Concerning Forward-Looking Statements

This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements that are based upon management’s current expectations, assumptions, estimates, projections and beliefs. The use of words such as, but not limited to, “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” and similar words or expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding future awards under the 2026 Plan. These statements involve risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by the forward-looking statements. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Other risks relating to the Company’s business, including risks that could cause results to differ materially from those projected in the forward-looking statements in this report, are detailed in the Company’s latest Form 10-K filed with the Securities and Exchange Commission on March 19, 2026. The forward-looking statements in this report speak only as of this date, and the Company disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.Description
3.1Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation.
3.2Amended and Restated Bylaws.
10.1NovaBay Pharmaceuticals, Inc. 2026 Equity Incentive Plan.
10.2Form of Restricted Stock Unit Agreement (Time-Based) (Michael Kazley).
10.3Form of Restricted Stock Unit Agreement (Time-Based).
10.4Form of Restricted Stock Unit Agreement (Performance-Based) (Michael Kazley).
10.5Employment Agreement, dated March 31, 2026, by and between NovaBay Pharmaceuticals, Inc. and Michael Kazley.
10.6Employment Agreement, dated March 31, 2026, by and between NovaBay Pharmaceuticals, Inc. and Tommy Law.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.